Literature DB >> 17979711

Phytochemical genistein in the regulation of vascular function: new insights.

Hongwei Si1, Dongmin Liu.   

Abstract

Genistein, a natural bioactive compound derived from legumes, has drawn wide attention during the last decade because of its potentially beneficial effects on some human degenerative diseases. It has a weak estrogenic effect and is a well-known non-specific tyrosine kinase inhibitor at pharmacological doses. Epidemiological studies show that genistein intake is inversely associated with the risk of cardiovascular diseases. Data from animal and in vitro studies suggest a protective role of genistein in cardiovascular events. However, the mechanisms of the genistein action on vascular protective effects are unclear. Past extensive studies exploring its hypolipidemic effect resulted in contradictory data. Genistein also is a relatively poor antioxidant. However, genistein protects against pro-inflammatory factor-induced vascular endothelial barrier dysfunction and inhibits leukocyte-endothelium interaction, thereby modulating vascular inflammation, a major event in the pathogenesis of atherosclerosis. Recent studies found that genistein exerts a novel non-genomic action by targeting on important signaling molecules in vascular endothelial cells (ECs). Genistein rapidly activates endothelial nitric oxide synthase and production of nitric oxide in ECs. This genistein effect is novel since it is independent of its known effects, but mediated by the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) cascade. Further studies demonstrated that genistein directly stimulates the plasma membrane-associated adenylate cyclases, leading to activation of the cAMP signaling pathway. In addition, genistein activates peroxisome proliferator-activated receptors, ligand-activated nuclear receptors important to normal vascular function. Furthermore, genistein reduces reactive oxygen species (ROS) by attenuating the expression of ROS-producing enzymes. These new findings reveal the novel roles for genistein in the regulation of vascular function and provide a basis for further investigating its therapeutic potential for inflammatory-related vascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979711     DOI: 10.2174/092986707782023325

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  29 in total

1.  Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice.

Authors:  Wei Qin; Ning Du; Longyin Zhang; Xianxian Wu; Yingying Hu; Xiaoguang Li; Nannan Shen; Yang Li; Baofeng Yang; Chaoqian Xu; Zhiwei Fang; Yanjie Lu; Yong Zhang; Zhimin Du
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

Review 2.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

3.  Genistein inhibits mitochondrial-targeted oxidative damage induced by beta-amyloid peptide 25-35 in PC12 cells.

Authors:  Yuan-Di Xi; Huan-Ling Yu; Wei-Wei Ma; Bing-Jie Ding; Juan Ding; Lin-Hong Yuan; Jin-Fang Feng; Rong Xiao
Journal:  J Bioenerg Biomembr       Date:  2011-07-06       Impact factor: 2.945

4.  Genistein prevents hyperglycemia-induced monocyte adhesion to human aortic endothelial cells through preservation of the cAMP signaling pathway and ameliorates vascular inflammation in obese diabetic mice.

Authors:  Pon Velayutham Anandh Babu; Hongwei Si; Zhuo Fu; Wei Zhen; Dongmin Liu
Journal:  J Nutr       Date:  2012-03-07       Impact factor: 4.798

5.  Genistein potentiates activity of the cation channel TRPC5 independently of tyrosine kinases.

Authors:  Ching-On Wong; Yu Huang; Xiaoqiang Yao
Journal:  Br J Pharmacol       Date:  2010-03-03       Impact factor: 8.739

6.  Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation.

Authors:  Ahmed S Ibrahim; Mamdouh M El-Shishtawy; Alejandro Peña; Gregory I Liou
Journal:  Mol Vis       Date:  2010-10-08       Impact factor: 2.367

Review 7.  Multi-targeted therapy of cancer by genistein.

Authors:  Sanjeev Banerjee; Yiwei Li; Zhiwei Wang; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2008-05-19       Impact factor: 8.679

8.  Cancer Prevention and Treatment by Wholistic Nutrition.

Authors:  T Colin Campbell
Journal:  J Nat Sci       Date:  2017-10

9.  Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries.

Authors:  Imad Sheiban; Matteo Anselmino; Claudio Moretti; Giuseppe Biondi-Zoccai; Marco Galloni; Cristina Vignolini; Mario Mattoni; Filippo Sciuto; Pierluigi Omedè; Gian Paolo Trevi
Journal:  Clin Res Cardiol       Date:  2008-09-05       Impact factor: 5.460

10.  Beta amyloid peptide (25-35) leading to inflammation through Toll-like receptors and the anti-inflammatory effect of genistein in BV-2 cells.

Authors:  Huan-Ling Yu; Xiao-Ying Li; Xin Zhou; Lin-Hong Yuan; Wei-Wei Ma; Yuan-Di Xi; Xia Zhao; Jian Wu; Rong Xiao
Journal:  J Mol Neurosci       Date:  2013-08-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.